Skip to main content
Erschienen in: Abdominal Radiology 7/2015

01.10.2015 | Pictorial Essay

Post-treated prostate cancer: normal findings and signs of local relapse on multiparametric magnetic resonance imaging

verfasst von: João Lopes Dias, Rita Lucas, João Magalhães Pina, Raquel João, Nuno Vasco Costa, Cecília Leal, Tiago Bilhim, Luís Campos Pinheiro, Rui Mateus Marques

Erschienen in: Abdominal Radiology | Ausgabe 7/2015

Einloggen, um Zugang zu erhalten

Abstract

The use of multiparametric magnetic resonance imaging (mp-MRI) for prostate cancer has increased over recent years, mainly for detection, staging, and active surveillance. However, suspicion of recurrence in the set of biochemical failure is becoming a significant reason for clinicians to request mp-MRI. Radiologists should be able to recognize the normal post-treatment MRI findings. Fibrosis and atrophic remnant seminal vesicles after prostatectomy are often found and must be differentiated from local relapse. Moreover, brachytherapy, external beam radiotherapy, cryosurgery, and hormonal therapy tend to diffusely decrease the signal intensity of the peripheral zone on T2-weighted images (T2WI) due to the loss of water content, consequently mimicking tumor and hemorrhage. The combination of T2WI and functional studies like diffusion-weighted imaging and dynamic contrast-enhanced improves the identification of local relapse. Tumor recurrence tends to restrict on diffusion images and avidly enhances after contrast administration either within or outside the gland. The authors provide a pictorial review of the normal findings and the signs of local tumor relapse after radical prostatectomy, external beam radiotherapy, brachytherapy, cryosurgery, and hormonal therapy.
Literatur
2.
Zurück zum Zitat Turkbey B, Albert PS, Kurdziel K, et al. (2009) Imaging localized prostate cancer: current approaches and new developments. AJR Am J Roentgenol 192(6):1471–1480PubMedCentralCrossRefPubMed Turkbey B, Albert PS, Kurdziel K, et al. (2009) Imaging localized prostate cancer: current approaches and new developments. AJR Am J Roentgenol 192(6):1471–1480PubMedCentralCrossRefPubMed
3.
Zurück zum Zitat Choi YJ, Kim JK, Kim N, et al. (2007) Functional MR imaging of prostate cancer. Radiographics 27(1):63–75CrossRefPubMed Choi YJ, Kim JK, Kim N, et al. (2007) Functional MR imaging of prostate cancer. Radiographics 27(1):63–75CrossRefPubMed
4.
Zurück zum Zitat Kirkham APS, Haslam P, Keanie JY, et al. (2013) Prostate MRI: who, when, and how? Report from a UK consensus meeting. Clin Radiol 68(10):1016–1023CrossRefPubMed Kirkham APS, Haslam P, Keanie JY, et al. (2013) Prostate MRI: who, when, and how? Report from a UK consensus meeting. Clin Radiol 68(10):1016–1023CrossRefPubMed
5.
Zurück zum Zitat Heidenreich A, Bellmunt J, Bolla M, et al. (2011) EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. Eur Urol 59(1):61–71CrossRefPubMed Heidenreich A, Bellmunt J, Bolla M, et al. (2011) EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. Eur Urol 59(1):61–71CrossRefPubMed
6.
Zurück zum Zitat Roach MR III, Hanks G, Thames H Jr, et al. (2006) Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys 65(4):965–974CrossRefPubMed Roach MR III, Hanks G, Thames H Jr, et al. (2006) Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys 65(4):965–974CrossRefPubMed
7.
Zurück zum Zitat Beresford MJ, Gillatt D, Benson RJ, et al. (2010) A systematic review of the role of imaging before salvage radiotherapy for post-prostatectomy biochemical recurrence statement of search strategies used and sources of information. Clin Oncol 22(1):46–55CrossRef Beresford MJ, Gillatt D, Benson RJ, et al. (2010) A systematic review of the role of imaging before salvage radiotherapy for post-prostatectomy biochemical recurrence statement of search strategies used and sources of information. Clin Oncol 22(1):46–55CrossRef
8.
Zurück zum Zitat Rouvière O, Vitry T, Lyonnet D (2010) Imaging of prostate cancer local recurrences: why and how? Eur Radiol 20:1254–1266CrossRefPubMed Rouvière O, Vitry T, Lyonnet D (2010) Imaging of prostate cancer local recurrences: why and how? Eur Radiol 20:1254–1266CrossRefPubMed
9.
Zurück zum Zitat Boorjian SA, Thompson RH, Tollefson MK, et al. (2011) Long-term risk of clinical progression after biochemical recurrence following radical prostatectomy: the impact of time from surgery to recurrence. Eur Urol 59(6):893–899CrossRefPubMed Boorjian SA, Thompson RH, Tollefson MK, et al. (2011) Long-term risk of clinical progression after biochemical recurrence following radical prostatectomy: the impact of time from surgery to recurrence. Eur Urol 59(6):893–899CrossRefPubMed
10.
Zurück zum Zitat Mottet N, Bellmunt J, Bolla M, et al. (2011) EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer. Eur Urol 59(4):572–583CrossRefPubMed Mottet N, Bellmunt J, Bolla M, et al. (2011) EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer. Eur Urol 59(4):572–583CrossRefPubMed
11.
Zurück zum Zitat Brogsitter C, Zöphel K, Kotzerke J (2013) 18F-Choline, 11C-choline and 11C-acetate PET/CT : comparative analysis for imaging prostate cancer patients. Eur J Nucl Med Mol Imaging 40(Suppl):S18–S27CrossRefPubMed Brogsitter C, Zöphel K, Kotzerke J (2013) 18F-Choline, 11C-choline and 11C-acetate PET/CT : comparative analysis for imaging prostate cancer patients. Eur J Nucl Med Mol Imaging 40(Suppl):S18–S27CrossRefPubMed
12.
Zurück zum Zitat Lecouvet E, El J, Collette L, et al. (2012) Can whole-body magnetic resonance imaging with diffusion-weighted imaging replace Tc 99 m bone scanning and computed tomography for single-step detection of metastases in patients with high-risk prostate cancer? Eur Urol 62:68–75CrossRefPubMed Lecouvet E, El J, Collette L, et al. (2012) Can whole-body magnetic resonance imaging with diffusion-weighted imaging replace Tc 99 m bone scanning and computed tomography for single-step detection of metastases in patients with high-risk prostate cancer? Eur Urol 62:68–75CrossRefPubMed
13.
Zurück zum Zitat Beer AJ, Eiber M, Souvatzoglou M, et al. (2011) Radionuclide and hybrid imaging of recurrent prostate cancer. Lancet Oncol 12(2):181–191CrossRefPubMed Beer AJ, Eiber M, Souvatzoglou M, et al. (2011) Radionuclide and hybrid imaging of recurrent prostate cancer. Lancet Oncol 12(2):181–191CrossRefPubMed
14.
Zurück zum Zitat Gomez P, Manoharan M, Kim SS, et al. (2004) Radionuclide bone scintigraphy in patients with biochemical recurrence after radical prostatectomy: when is it indicated? BJU Int 94:299–302CrossRefPubMed Gomez P, Manoharan M, Kim SS, et al. (2004) Radionuclide bone scintigraphy in patients with biochemical recurrence after radical prostatectomy: when is it indicated? BJU Int 94:299–302CrossRefPubMed
15.
Zurück zum Zitat Gutzeit A, Doert A, Froehlich JM, et al. (2010) Comparison of diffusion-weighted whole body MRI and skeletal scintigraphy for the detection of bone metastases in patients with prostate or breast carcinoma. Skeletal Radiol 39:333–343CrossRefPubMed Gutzeit A, Doert A, Froehlich JM, et al. (2010) Comparison of diffusion-weighted whole body MRI and skeletal scintigraphy for the detection of bone metastases in patients with prostate or breast carcinoma. Skeletal Radiol 39:333–343CrossRefPubMed
16.
Zurück zum Zitat Fuccio C, Castellucci P, Schiavina R, et al. (2012) Role of 11C-choline PET/CT in the re-staging of prostate cancer patients with biochemical relapse and negative results at bone scintigraphy. Eur J Radiol 81:893–896CrossRef Fuccio C, Castellucci P, Schiavina R, et al. (2012) Role of 11C-choline PET/CT in the re-staging of prostate cancer patients with biochemical relapse and negative results at bone scintigraphy. Eur J Radiol 81:893–896CrossRef
17.
Zurück zum Zitat Luboldt W, Kufer R, Blumstein N, et al. (2008) Prostate carcinoma: diffusion-weighted imaging as potential alternative to conventional MR and 11C-choline PET/CT for detection of bone metastases. Radiology 249(3):1017–1025CrossRefPubMed Luboldt W, Kufer R, Blumstein N, et al. (2008) Prostate carcinoma: diffusion-weighted imaging as potential alternative to conventional MR and 11C-choline PET/CT for detection of bone metastases. Radiology 249(3):1017–1025CrossRefPubMed
18.
Zurück zum Zitat Eiber M, Holzapfel K, Ganter C, et al. (2011) Whole-body MRI including diffusion-weighted imaging (DWI) for patients with recurring prostate cancer: technical feasibility and assessment of lesion conspicuity in DWI. J Magn Reson Imaging 33:1160–1170CrossRefPubMed Eiber M, Holzapfel K, Ganter C, et al. (2011) Whole-body MRI including diffusion-weighted imaging (DWI) for patients with recurring prostate cancer: technical feasibility and assessment of lesion conspicuity in DWI. J Magn Reson Imaging 33:1160–1170CrossRefPubMed
19.
Zurück zum Zitat Liauw SL, Pitroda SP, Eggener SE, et al. (2013) Evaluation of the prostate bed for local recurrence after radical prostatectomy using endorectal magnetic resonance imaging. Int J Radiat Oncol Biol Phys 85(2):378–384CrossRefPubMed Liauw SL, Pitroda SP, Eggener SE, et al. (2013) Evaluation of the prostate bed for local recurrence after radical prostatectomy using endorectal magnetic resonance imaging. Int J Radiat Oncol Biol Phys 85(2):378–384CrossRefPubMed
20.
Zurück zum Zitat Joniau S, Van den Bergh L, Lerut E, et al. (2013) Mapping of pelvic lymph node metastases in prostate cancer. Eur Urol 63(3):450–458CrossRefPubMed Joniau S, Van den Bergh L, Lerut E, et al. (2013) Mapping of pelvic lymph node metastases in prostate cancer. Eur Urol 63(3):450–458CrossRefPubMed
21.
Zurück zum Zitat Tewari A, Sooriakumaran P, Bloch D, et al. (2012) Positive surgical margin and perioperative complication rates of primary surgical treatments for prostate cancer: a systematic review and meta-analysis comparing retropubic, laparoscopic, and robotic prostatectomy. Eur Urol 62(1):1–15CrossRefPubMed Tewari A, Sooriakumaran P, Bloch D, et al. (2012) Positive surgical margin and perioperative complication rates of primary surgical treatments for prostate cancer: a systematic review and meta-analysis comparing retropubic, laparoscopic, and robotic prostatectomy. Eur Urol 62(1):1–15CrossRefPubMed
22.
Zurück zum Zitat Park BH, Jeon HG, Jeong BC, et al. (2014) Influence of magnetic resonance imaging in the decision to preserve or resect neurovascular bundles at robotic assisted laparoscopic radical prostatectomy. J Urol 192(1):82–88CrossRefPubMed Park BH, Jeon HG, Jeong BC, et al. (2014) Influence of magnetic resonance imaging in the decision to preserve or resect neurovascular bundles at robotic assisted laparoscopic radical prostatectomy. J Urol 192(1):82–88CrossRefPubMed
23.
Zurück zum Zitat Briganti A, Joniau S, Gontero P, et al. (2012) Identifying the best candidate for radical prostatectomy among patients with high-risk prostate cancer. Eur Urol 61:584–592CrossRefPubMed Briganti A, Joniau S, Gontero P, et al. (2012) Identifying the best candidate for radical prostatectomy among patients with high-risk prostate cancer. Eur Urol 61:584–592CrossRefPubMed
24.
Zurück zum Zitat Joniau S, Hsu C-Y, Gontero P, et al. (2012) Radical prostatectomy in very high-risk localized prostate cancer: long-term outcomes and outcome predictors. Scand J Urol Nephrol 46(3):164–171CrossRefPubMed Joniau S, Hsu C-Y, Gontero P, et al. (2012) Radical prostatectomy in very high-risk localized prostate cancer: long-term outcomes and outcome predictors. Scand J Urol Nephrol 46(3):164–171CrossRefPubMed
25.
Zurück zum Zitat Roethke MC, Lichy MP, Kniess M, et al. (2013) Accuracy of preoperative endorectal MRI in predicting extracapsular extension and influence on neurovascular bundle sparing in radical prostatectomy. World J Urol 31(5):1111–1116CrossRefPubMed Roethke MC, Lichy MP, Kniess M, et al. (2013) Accuracy of preoperative endorectal MRI in predicting extracapsular extension and influence on neurovascular bundle sparing in radical prostatectomy. World J Urol 31(5):1111–1116CrossRefPubMed
26.
Zurück zum Zitat Panebianco V, Salciccia S, Cattarino S, et al. (2012) Use of multiparametric MR with neurovascular bundle evaluation to optimize the oncological and functional management of patients considered for nerve-sparing radical prostatectomy. J Sex Med 9:2157–2166CrossRefPubMed Panebianco V, Salciccia S, Cattarino S, et al. (2012) Use of multiparametric MR with neurovascular bundle evaluation to optimize the oncological and functional management of patients considered for nerve-sparing radical prostatectomy. J Sex Med 9:2157–2166CrossRefPubMed
27.
Zurück zum Zitat Pound CR, Partin AW, Eisenberger MA, et al. (1999) Natural history of progression after PSA elevation following radical prostatectomy. JAMA 281(17):1591–1597CrossRefPubMed Pound CR, Partin AW, Eisenberger MA, et al. (1999) Natural history of progression after PSA elevation following radical prostatectomy. JAMA 281(17):1591–1597CrossRefPubMed
28.
Zurück zum Zitat Amling CL, Bergstralh EJ, Blute ML, et al. (2001) Defining prostate specific antigen progression after radical prostatectomy: what is the most appropriate cut point? J Urol 165(April):1146–1151CrossRefPubMed Amling CL, Bergstralh EJ, Blute ML, et al. (2001) Defining prostate specific antigen progression after radical prostatectomy: what is the most appropriate cut point? J Urol 165(April):1146–1151CrossRefPubMed
29.
Zurück zum Zitat Cirillo S, Petracchini M, Scotti L, et al. (2009) Endorectal magnetic resonance imaging at 1.5 Tesla to assess local recurrence following radical prostatectomy using T2-weighted and contrast-enhanced imaging. Eur Radiol 19:761–769CrossRefPubMed Cirillo S, Petracchini M, Scotti L, et al. (2009) Endorectal magnetic resonance imaging at 1.5 Tesla to assess local recurrence following radical prostatectomy using T2-weighted and contrast-enhanced imaging. Eur Radiol 19:761–769CrossRefPubMed
30.
Zurück zum Zitat Sciarra A, Panebianco V, Salciccia S, et al. (2008) Role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer. Eur Urol 54:589–600CrossRefPubMed Sciarra A, Panebianco V, Salciccia S, et al. (2008) Role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer. Eur Urol 54:589–600CrossRefPubMed
31.
Zurück zum Zitat Sella T, Schwartz LH, Swindle PW, et al. (2004) Suspected local recurrence after radical prostatectomy: endorectal coil MR imaging. Radiology 231:379–385CrossRefPubMed Sella T, Schwartz LH, Swindle PW, et al. (2004) Suspected local recurrence after radical prostatectomy: endorectal coil MR imaging. Radiology 231:379–385CrossRefPubMed
32.
Zurück zum Zitat Casciani E, Polettini E, Carmenini E, et al. (2008) Endorectal and dynamic contrast-enhanced MRI for detection of local recurrence after radical prostatectomy. Acta Radiol 190(5):1187–1192 Casciani E, Polettini E, Carmenini E, et al. (2008) Endorectal and dynamic contrast-enhanced MRI for detection of local recurrence after radical prostatectomy. Acta Radiol 190(5):1187–1192
33.
Zurück zum Zitat Nilsson S, Norlén BJ, Widmark A (2004) A systematic overview of radiation therapy effects in prostate cancer. Acta Oncol (Madr) 43(4):316–381CrossRef Nilsson S, Norlén BJ, Widmark A (2004) A systematic overview of radiation therapy effects in prostate cancer. Acta Oncol (Madr) 43(4):316–381CrossRef
34.
Zurück zum Zitat Haider M, Chung P, Sweet J, et al. (2008) Dynamic contrast-enhanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy. Int J Radiat Oncol Biol Phys 70(2):425–430CrossRefPubMed Haider M, Chung P, Sweet J, et al. (2008) Dynamic contrast-enhanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy. Int J Radiat Oncol Biol Phys 70(2):425–430CrossRefPubMed
35.
Zurück zum Zitat Kim C, Park B, Lee H (2009) Prediction of locally recurrent prostate cancer after radiation therapy: incremental value of 3T diffusion-weighted MRI. J Magn Reson Imaging 29(2):391–397CrossRefPubMed Kim C, Park B, Lee H (2009) Prediction of locally recurrent prostate cancer after radiation therapy: incremental value of 3T diffusion-weighted MRI. J Magn Reson Imaging 29(2):391–397CrossRefPubMed
36.
Zurück zum Zitat Morgan V, Riches S, Giles S, et al. (2012) Diffusion-weighted MRI for locally recurrent prostate cancer after external beam radiotherapy. AJR Am J Roentgenol 198(3):596–602CrossRefPubMed Morgan V, Riches S, Giles S, et al. (2012) Diffusion-weighted MRI for locally recurrent prostate cancer after external beam radiotherapy. AJR Am J Roentgenol 198(3):596–602CrossRefPubMed
37.
Zurück zum Zitat Donati OF, Il Jung S, Vargas HA, et al. (2013) Multiparametric prostate MR imaging with T2-weighted, diffusion-weighted, and dynamic contrast-enhanced sequences: are all pulse sequences necessary to detect locally recurrent prostate cancer after radiation therapy? Radiology 268(2):440–450CrossRefPubMed Donati OF, Il Jung S, Vargas HA, et al. (2013) Multiparametric prostate MR imaging with T2-weighted, diffusion-weighted, and dynamic contrast-enhanced sequences: are all pulse sequences necessary to detect locally recurrent prostate cancer after radiation therapy? Radiology 268(2):440–450CrossRefPubMed
38.
Zurück zum Zitat Arumainayagam N, Kumaar S, Ahmed HU, et al. (2010) Accuracy of multiparametric magnetic resonance imaging in detecting recurrent prostate cancer after radiotherapy. BJU Int 106:991–997CrossRefPubMed Arumainayagam N, Kumaar S, Ahmed HU, et al. (2010) Accuracy of multiparametric magnetic resonance imaging in detecting recurrent prostate cancer after radiotherapy. BJU Int 106:991–997CrossRefPubMed
39.
Zurück zum Zitat Akin O, Gultekin DH, Vargas HA, et al. (2011) Incremental value of diffusion weighted and dynamic contrast enhanced MRI in the detection of locally recurrent prostate cancer after radiation treatment : preliminary results. Eur Radiol 21:1970–1978PubMedCentralCrossRefPubMed Akin O, Gultekin DH, Vargas HA, et al. (2011) Incremental value of diffusion weighted and dynamic contrast enhanced MRI in the detection of locally recurrent prostate cancer after radiation treatment : preliminary results. Eur Radiol 21:1970–1978PubMedCentralCrossRefPubMed
40.
Zurück zum Zitat Pucar D, Hricak H, Kuroiwa K, et al. (2005) Prostate cancer: correlation of MR imaging and MR spectroscopy with pathologic findings after radiation therapy—initial experience. Radiology 236:545–553PubMedCentralCrossRefPubMed Pucar D, Hricak H, Kuroiwa K, et al. (2005) Prostate cancer: correlation of MR imaging and MR spectroscopy with pathologic findings after radiation therapy—initial experience. Radiology 236:545–553PubMedCentralCrossRefPubMed
41.
Zurück zum Zitat Ash D, Flynn A, Battermann J, et al. (2000) ESTRO/EAU/EORTC recommendations on permanent seed implantation for localized prostate cancer. Radiother Oncol 57:315–321CrossRefPubMed Ash D, Flynn A, Battermann J, et al. (2000) ESTRO/EAU/EORTC recommendations on permanent seed implantation for localized prostate cancer. Radiother Oncol 57:315–321CrossRefPubMed
42.
Zurück zum Zitat Han K, Belldegrun A (2004) Third-generation cryosurgery for primary and recurrent prostate cancer. BJU Int 93:14–18CrossRefPubMed Han K, Belldegrun A (2004) Third-generation cryosurgery for primary and recurrent prostate cancer. BJU Int 93:14–18CrossRefPubMed
43.
Zurück zum Zitat Fahmy W, Bissada N (2003) Cryosurgery for prostate cancer. Arch Androl 49:397–407PubMed Fahmy W, Bissada N (2003) Cryosurgery for prostate cancer. Arch Androl 49:397–407PubMed
44.
Zurück zum Zitat Rees J, Patel B, Macdonagh R, et al. (2004) Cryosurgery for prostate cancer. BJU Int 93:710–714CrossRefPubMed Rees J, Patel B, Macdonagh R, et al. (2004) Cryosurgery for prostate cancer. BJU Int 93:710–714CrossRefPubMed
45.
Zurück zum Zitat Aus G (2006) Current status of HIFU and cryotherapy in prostate cancer—a review. Eur Urol 50(5):927–934CrossRefPubMed Aus G (2006) Current status of HIFU and cryotherapy in prostate cancer—a review. Eur Urol 50(5):927–934CrossRefPubMed
46.
Zurück zum Zitat Parivar F, Hricak H, Shinohara K, et al. (1996) Detection of locally recurrent prostate cancer after cryosurgery: evaluation by transrectal ultrasound, magnetic resonance imaging, and three-dimensional proton magnetic resonance spectroscopy. Urology 48(4):594–599CrossRefPubMed Parivar F, Hricak H, Shinohara K, et al. (1996) Detection of locally recurrent prostate cancer after cryosurgery: evaluation by transrectal ultrasound, magnetic resonance imaging, and three-dimensional proton magnetic resonance spectroscopy. Urology 48(4):594–599CrossRefPubMed
47.
Zurück zum Zitat Sharifi N, Gulley JL, Dahut WL (2005) Androgen deprivation therapy for prostate cancer. JAMA 294(2):238–244CrossRefPubMed Sharifi N, Gulley JL, Dahut WL (2005) Androgen deprivation therapy for prostate cancer. JAMA 294(2):238–244CrossRefPubMed
48.
Zurück zum Zitat Hussain M, Tangen C, Higano C, et al. (2006) absolute prostate-specific antigen value after androgen deprivation is a strong independent predictor of survival in new metastatic prostate cancer: data from Southwest Oncology Group Trial 9346 (INT-0162). J Clin Oncol 24(24):3984–3990CrossRefPubMed Hussain M, Tangen C, Higano C, et al. (2006) absolute prostate-specific antigen value after androgen deprivation is a strong independent predictor of survival in new metastatic prostate cancer: data from Southwest Oncology Group Trial 9346 (INT-0162). J Clin Oncol 24(24):3984–3990CrossRefPubMed
49.
Zurück zum Zitat Stewart A, Scher H, Chen M, et al. (2005) Prostate-specific antigen nadir and cancer-specific mortality following hormonal therapy for prostate-specific antigen failure. J Clin Oncol 23(27):6556–6560CrossRefPubMed Stewart A, Scher H, Chen M, et al. (2005) Prostate-specific antigen nadir and cancer-specific mortality following hormonal therapy for prostate-specific antigen failure. J Clin Oncol 23(27):6556–6560CrossRefPubMed
Metadaten
Titel
Post-treated prostate cancer: normal findings and signs of local relapse on multiparametric magnetic resonance imaging
verfasst von
João Lopes Dias
Rita Lucas
João Magalhães Pina
Raquel João
Nuno Vasco Costa
Cecília Leal
Tiago Bilhim
Luís Campos Pinheiro
Rui Mateus Marques
Publikationsdatum
01.10.2015
Verlag
Springer US
Erschienen in
Abdominal Radiology / Ausgabe 7/2015
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-015-0473-1

Weitere Artikel der Ausgabe 7/2015

Abdominal Radiology 7/2015 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.